TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$21.52
0.45 (2.14%)
▲
5d:
-4.01%
30d:
-15.11%
90d:
+22.9%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
TXG is down 7.3% this week, but smart money is accumulating calls. Top strike: $22.5 2026-06-18 with 96 OI. Call ratio: 64% View Scanner →
Strength: 5.1/10
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TXG trading at deep discount. Market pricing in -4.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: TXG trading at deep discount. Market pricing in -4.1% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $21.52, which is considered slightly low relative to its 30-day fair value range of $21.13 to $24.02. From a valuation perspective, the stock is trading at a discount (Forward PE: 107.6) compared to its historical average (121.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TXG is in a uptrend. Immediate support is located at $19.82, while resistance sits at $23.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+16.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TXG is in a uptrend. Immediate support is located at $19.82, while resistance sits at $23.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+16.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$21.13 -
$24.02
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($25.00)
Trading Range Analysis
30-Day Trading Range
$21.13 -
$24.02
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$19.82
Resistance Level
$23.15
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
107.60
Wall Street Target
$25.00
(+16.2%)
Revenue Growth (YoY)
-2.6%
Profit Margin
-3.5%
Valuation Discount vs History
-4.1% cheaper
PE vs Historical
107.6 vs 121.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.1%
(market-implied from PE analysis)
1-Year Target
$20.64
(-4%)
2-Year Target
$19.79
(-8%)
3-Year Target
$18.98
(-12%)
3-Yr Target (if PE normalizes)
(PE: 108→122)
$21.48
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 107.6 to 121.8
Stabilization Target:
$24.36
(+13.2%)
PE Expansion Potential:
+13.2%
Share & Embed Analysis
Last updated: May 14, 2026 10:47 PM ET
Data refreshes hourly during market hours. Next update: 11:47 PM
Data refreshes hourly during market hours. Next update: 11:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$16 | 54 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 60 HOLD |
